Items Tagged ‘General Thyroid Cancer’

April 6th, 2016

Complications Decrease with Surgeon Experience in Thyroidectomy

By

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These results were recently published in the Annals of Surgery. The thyroid is a small, butterfly-shaped gland that is located at the base of the neck. It […]

View full entry

Tags: complications, failure, General Thyroid Cancer, success, surgeon, surgery, Thyroid Cancer, thyroidectomy


December 9th, 2013

Nexavar Approved for Metastatic Differentiated Thyroid Cancer

By

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery and radioactive iodine (RAI) treatment. In some cases, however, the cancer is resistant to RAI. RAI-resistant thyroid cancers […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


November 15th, 2013

Mutations Linked to Drug Response in Medullary Thyroid Cancer

By

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study presented at the 83rd Annual Meeting of the American Thyroid Association, October 16- 20, 2013, in San Juan, Puerto Rico. The thyroid is a gland in the throat […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


November 4th, 2013

TSH Suppression after Thyroidectomy May Not Be Beneficial

By

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women, according to the results of a study presented at the 83rd Annual Meeting of the American Thyroid Association, October 16- 20, 2013, in San Juan, […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


September 13th, 2013

Thyroid Ultrasound May Cut Biopsy Rate

By

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the results of a study published in the Journal of the American Medical Association. The thyroid gland is located in the front of the neck and is attached to […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


June 5th, 2013

BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer

By

The presence of the BRAF V600E mutation is significantly associated with increased cancer-related death among patients with papillary thyroid cancer, according to the results of a study published in the Journal of the American Medical Association. The thyroid gland is located in the front of the neck and is attached to the lower part of the voice box […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


March 28th, 2013

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer

By

The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the results of a study published in the New England Journal of Medicine. The thyroid is a gland in the throat that produces hormones mostly related to […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


August 30th, 2012

Targeted Drug Caprelsa Slows Thyroid Cancer

By

The targeted drug Caprelsa® (vandetanib) delays progression in advanced differentiated thyroid cancer, according to the results of a study published in The Lancet Oncology. The thyroid is a gland in the throat that produces hormones mostly related to metabolic processes in the body. Nearly 95% of all thyroid cancers are classified as differentiated thyroid cancers; the […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


June 28th, 2012

Gene Expression Test Identifies Low-Risk Thyroid Nodules

By

A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study published early online in the New England Journal of Medicine.[1] The thyroid gland is located in the front of the neck and is attached to the […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


May 10th, 2012

Low-Dose Radioiodine Effective in Thyroid Cancer

By

Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean that radiation doses could be cut to one-third of the current level. The thyroid is a gland in the throat that produces hormones […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


March 26th, 2012

Aspirin Continues to Look Promising for Cancer Prevention

By

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce the risk of several types of cancer, with particularly strong evidence […]

View full entry

Tags: Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, General Bone Cancer, General Brain Cancer, General Head and Neck Cancer


October 28th, 2011

Cabozantinib Shows Benefit in Medullary Thyroid Cancer

By

In a Phase III clinical trial, the investigational drug cabozantinib significantly delayed the progression of advanced medullary thyroid cancer. Detailed results are expected to be presented at an upcoming medical conference. Medullary thyroid cancers account for approximately 2-3% of all thyroid cancers. These cancers tend to have a somewhat worse prognosis than more common types […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


August 29th, 2011

Use of Radioactive Iodine for Thyroid Cancer Has Increased

By

Use of radioactive iodine for the treatment of well-differentiated thyroid cancer has increased over time in the United States, even among patients who have an excellent prognosis with surgery alone. These results were published in the Journal of the American Medical Association. The thyroid is a gland in the throat that produces hormones mostly related […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


July 15th, 2011

Stay on Top of Your Family History of Cancer

By

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically with your healthcare provider. This was the conclusion of a study published in […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, General Bone Cancer


June 9th, 2011

Fosbretabulin Tromethamine in Addition to Chemotherapy may Improve Survival in Advanced Thyroid Cancer

By

The addition of fosbretabulin tromethamine (CA4P) to standard chemotherapy significantly improved survival at one year compared to chemotherapy alone in advanced anaplastic thyroid cancer. These results were recently presented at the 2011 annual meeting of the American Society of Clinical Oncology. The thyroid is a gland in the throat that produces hormones mostly related to […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer